Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -6.55% is 39% above its 5-year average of -10.80%, near the high end of its 5-year range (-57.28%–1.93%).
1.54% below its 12-month average of -6.45%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 1.93%.
NET PROFIT MARGIN
-6.55%
NET PROFIT MARGIN AVG TTM
-6.45%
NET PROFIT MARGIN AVG 3Y
-5.81%
NET PROFIT MARGIN AVG 5Y
-10.80%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1.54%
CURRENT VS 3Y AVG
-12.78%
CURRENT VS 5Y AVG
+39.35%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.02%
median of 851 covered companies
CURRENT VS SECTOR MEDIAN
-32650.00%
vs the sector median at left
P3 Health Partners Inc.
Market Cap
$19.30M
Net Profit Margin
-6.55%
TTM Avg
-6.45%
3Y Avg
-5.81%
5Y Avg
-10.80%
Market Cap
$19.39M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$18.54M
Net Profit Margin
-1578.40%
TTM Avg
-574.01%
3Y Avg
-287.00%
5Y Avg
-1306.57%
Market Cap
$20.32M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-27.26%
Market Cap
$17.71M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$17.50M
Net Profit Margin
-33.08%
TTM Avg
-29.53%
3Y Avg
-30.32%
5Y Avg
-22.32%
Market Cap
$17.27M
Net Profit Margin
-10794.64%
TTM Avg
946.68%
3Y Avg
-6081.70%
5Y Avg
-5732.70%
Market Cap
$21.40M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$17.11M
Net Profit Margin
-755.13%
TTM Avg
-243.50%
3Y Avg
-516.28%
5Y Avg
-344.84%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| P3 Health Partners Inc. (PIII) | $19.30M | -6.55% | -6.45% | -5.81% | -10.80% |
| Actuate Therapeutics Inc (ACTU)vs › | $19.39M | 0.00% | 0.00% | 0.00% | 0.00% |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.54M | -1578.40% | -574.01% | -287.00% | -1306.57% |
| NextCure, Inc. (NXTC)vs › | $20.32M | 0.00% | 0.00% | 0.00% | -27.26% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.71M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cosmos Health Inc. (COSM)vs › | $17.50M | -33.08% | -29.53% | -30.32% | -22.32% |
| PAVmed Inc. (PAVM)vs › | $17.27M | -10794.64% | 946.68% | -6081.70% | -5732.70% |
| Quantum BioPharma Ltd. (QNTM)vs › | $21.40M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lipocine Inc. (LPCN)vs › | $17.11M | -755.13% | -243.50% | -516.28% | -344.84% |
| Modular Medical, Inc. (MODD)vs › | $21.56M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-18.5%
Net Profit Margin
-6.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 1.93% |
| 2026-03-31 | 0.32% |
| 2025-12-31 | -19.62% |
| 2025-09-30 | -9.15% |
| 2025-06-30 | -5.72% |
| 2025-03-31 | -5.49% |
| 2024-12-31 | -15.81% |
| 2024-09-30 | -12.84% |
| 2024-06-30 | -3.17% |
| 2024-03-31 | -4.81% |
| 2023-12-31 | -7.34% |
| 2023-09-30 | -4.61% |
| 2023-06-30 | -2.98% |
| 2023-03-31 | -3.05% |
| 2022-12-31 | -36.41% |
| 2022-09-30 | -4.50% |
| 2022-06-30 | -57.28% |
| 2022-03-31 | -3.87% |
| 2021-12-31 | -37.95% |
| 2021-09-30 | -20.52% |
| 2021-06-30 | -20.38% |
| 2021-03-31 | -16.29% |
| 2020-12-31 | -2.82% |
| 2020-09-30 | -12.97% |
| 2020-06-30 | -3.58% |
| 2020-03-31 | -5.95% |
